Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autonomic Neuromodulation With Ultrasound-Guided Stellate Ganglion Block in Alzheimer's Disease: A Randomized Controlled Trial

NCT07351773 is registered in ClinicalTrials.gov with Taizhou Second People's Hospital as lead sponsor.

NCT NCT07351773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07351773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autonomic Neuromodulation With Ultrasound-Guided Stellate Ganglion Block in Alzheimer's Disease: A Randomized Controlled Trial
Lead sponsor
Taizhou Second People's Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 26, 2025
Completion date
November 29, 2025
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease(ad), cognitive dysfunction